339 related articles for article (PubMed ID: 25257270)
21. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
22. Prospective trial of chemotherapy-enhanced accelerated radiotherapy for larynx preservation in patients with intermediate-volume hypopharyngeal cancer.
Kawashima M; Hayashi R; Tahara M; Arahira S; Miyazaki M; Sakuraba M; Zenda S; Ogino T
Head Neck; 2012 Oct; 34(10):1363-8. PubMed ID: 22076936
[TBL] [Abstract][Full Text] [Related]
23. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
24. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
[TBL] [Abstract][Full Text] [Related]
25. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
Komatsu M; Shiono O; Taguchi T; Sakuma Y; Nishimura G; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi M; Isitoya J; Oridate N
Jpn J Clin Oncol; 2014 May; 44(5):416-21. PubMed ID: 24688084
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.
Fury MG; Xiao H; Sherman EJ; Baxi S; Smith-Marrone S; Schupak K; Gewanter R; Gelblum D; Haque S; Schoder H; Shah JP; Katabi N; Kurtzman R; Lipson B; Cox L; Lee NY; Pfister DG
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E566-70. PubMed ID: 25784616
[TBL] [Abstract][Full Text] [Related]
27. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
28. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
29. Sequential four-drug chemotherapy and intensity-modulated radiotherapy for larynx preservation in resectable advanced larynx and hypopharynx cancer: A pilot study.
Su X; He C; Tang T; Chen W; Li Z; Chen Y; Yang A
Am J Otolaryngol; 2017; 38(1):52-56. PubMed ID: 27825651
[TBL] [Abstract][Full Text] [Related]
30. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of current and emerging approaches in the field of larynx preservation.
Denaro N; Russi EG; Lefebvre JL; Merlano MC
Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
[TBL] [Abstract][Full Text] [Related]
32. [New Combination Therapy to Improve the Functional Preservation Rate of the Larynx in Laryngeal, Oropharyngeal, and Hypopharyngeal Cancers].
Furusaka T
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1141-7. PubMed ID: 26489542
[TBL] [Abstract][Full Text] [Related]
33. Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer.
Huang WY; Jen YM; Chen CM; Su YF; Lin CS; Lin YS; Chang YN; Chao HL; Lin KT; Chang LP
Radiat Oncol; 2010 May; 5():37. PubMed ID: 20470428
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of nimotuzumab plus cisplatin and fluorouracil regimen as induction treatment in resectable head and neck squamous cell carcinoma].
Zhao XY; Guo Y; Zhu YX; Wang Y; Zhu GP; Hu CS; Ji QH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jul; 47(7):536-9. PubMed ID: 22932235
[TBL] [Abstract][Full Text] [Related]
35. [Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].
Kubota A; Furukawa M; Komatsu M; Hanamura H; Sugiyama M
Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):149-56. PubMed ID: 16615429
[TBL] [Abstract][Full Text] [Related]
36. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
37. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.
Edson MA; Garden AS; Takiar V; Glisson BS; Fuller CD; Gunn GB; Beadle BM; Morrison WH; Frank SJ; Shah SJ; Tao R; William WN; Weber RS; Rosenthal DI; Phan J
Head Neck; 2016 Apr; 38 Suppl 1():E2091-9. PubMed ID: 26920665
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.
Fayette J; Bonnin N; Ferlay C; Lallemant B; Ramade A; Favrel V; Zrounba P; Chabaud S; Pommier P; Poupart M; Céruse P
Anticancer Drugs; 2013 Jul; 24(6):623-9. PubMed ID: 23542750
[TBL] [Abstract][Full Text] [Related]
39. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR
Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242
[TBL] [Abstract][Full Text] [Related]
40. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
